**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 123334-21-4 |Lithium tetrachloropalladate(II) hydra| 99 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Hygroscopic (absorbs moisture from the air).The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this
material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
No information found.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Do not allow contact with water. Keep from contact with
moist air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 15525-45-8:
CAS# 123334-21-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: red-brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: Cl4Li2Pd.xH2O
Molecular Weight: 262.08
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, moisture, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, chloride fumes, lithium oxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 15525-45-8 unlisted.
CAS# 123334-21-4 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Dilithium tetrachloropalladate(2-) anhydrous -
Not listed by ACGIH, IARC, or NTP.
Lithium tetrachloropalladate(II) hydrate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 15525-45-8: No information available.
CAS# 123334-21-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 15525-45-8 is not listed on Canada's Ingredient Disclosure List.
CAS# 123334-21-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 15525-45-8 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 123334-21-4 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 1/18/1999 Revision #3 Date: 10/05/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ruthenium(III) Nitrosyl Chloride Monohydrate
| 18902-42-6 |
|
Hexaammineruthenium(III) Chloride
| 14282-91-8 |
|
1,2-Bis(diphenylphosphino)ethane nickel(II) chloride
| 14647-23-5 |
|
Tris(hydroxymethyl)phosphine
| 2767-80-8 |
|
2-Ethoxybenzaldehyde, 97+%
| 613-69-4 |
|
Methyl 3-Amino-2-Pyrazinecarboxylate, 98%
| 16298-03-6 |
|
Guanidine Hydrochloride without Anticaking Agent, 98%
| 50-01-1 |
|
Bis(Cyclopentadienyl)Osmium
| 1273-81-0 |
|
Scandium(III) Trifluoromethanesulfonate
| 144026-79-9 |
|
Tetraammineplatinum(II) nitrate
| 20634-12-2 |
|
Hydrogen hexachloroplatinate(IV) hexahydrate
| 16941-12-1 |
|
(S)-(-)-alpha-Methoxy-alpha-(Trifluoruomethyl)Phenylacetic Acid
| 17257-71-5 |
|
1,1'-(Methylenedi-p-phenylene)bis[3-(2-hydroxyethyl)]urea
| 7747-61-7 |
|
1,1'-(Methylenedi-p-phenylene)bis[3-(3-hydroxypropyl)]urea
| 20006-61-5 |
|
4-Methyl-2-Oxopentanoic Acid, Sodium Salt
| 4502-00-5 |
|
Cyclohexyltriphenylphosphonium Bromide, 97%
| 7333-51-9 |
|
Benzyltrimethylammonium Bromide
| 5350-41-4 |
|
Dehydroacetic Acid Sodium Salt, 99%
| 4418-26-2 |
|
Tris(2,6-dimethoxyphenyl)phosphine
| 85417-41-0 |
|
1-[1-(4-Chlorophenyl)Cyclobutyl]-3-Methylisobutylamine Hydrochloride
| 84484-78-6 |
|
1-(4-Chlorophenyl)-1-Cyclobutanecarbonitrile
| 28049-61-8 |
|
1,4-Phenylenediacetic acid, 97%
| 7325-46-4 |
|
1-(4-Methoxyphenyl)-1-Cyclopentanecarbonitrile
| 1206-15-1 |
|
15-Hydroxypentadecanoic Acid
| 4617-33-8 |
|
1,1,1-Trifluoro-2-Phenylbuten-2-ol
| 134418-70-5 |
|
1,1,1-Trifluoro-2-Phenylbutyn-2-ol
| 99727-20-5 |
|
3-Hydroxybutyonitrile
| 4368-06-3 |
|
Diacetone-d-glucose, 98+%
| 582-52-5 |
|
3,4-Epoxy-2-phenyl-1,1,1-trifluoro-2-butanol, mixture of
| 351003-37-7 |
|
3-Aminophenylacetylene
| 54060-30-9 |
|
Sodium Pivalate Hydrate, 99%
| 143174-36-1 |
|
Lithium tetrachloropalladate(II) hydrate, 99%
| 15525-45-8 |
|
Chlorobenzene
| 108-90-7 |
|
6-Bromo-1-Hexene, 97%
| 2695-47-8 |
|
Tributyl Citrate, 97%
| 77-94-1 |
|
Potassium tert-butoxide, 20 wt.% solution in THF
| 109-99-9 |
|
L-tert-Leucine-Tert-Butylester Hydrochloride
| 0-01-1 |
|
4-Keto-4,5,6,7-tetrahydrothianaphthene
| 13414-95-4 |
|
6-Hydroxyquinoline, 98%
| 580-16-5 |
|
DL-1-Aminoindane-1-Carboxylic Acid Hydrate, 98%
| 0-01-1 |
|
Maleic anhydride
| 108-31-6 |
|
2-Methyl-5-Nitroaniline, 96%
| 99-55-8 |
|
Heptane, for HPLC (99% n-Heptane)
| 142-82-5 |
|
beta-Nicotinamide Adenine Dinucleotide, Sodium Salt
| 20111-18-6 |
|
1-Bromopentadecane
| 629-72-1 |
|
2-Chlorobenzothiazole, 99%
| 615-20-3 |
|
2-Methylresorcinol, 98%
| 608-25-3 |
|
Ruthenium(III) nitrosyl nitrate, in diluted Nitric acid
| 7697-37-2 |
|
Ciprofibrate
| 52214-84-3 |
|
1-(4-Methylphenyl)-2-methylpiperazine
| 35947-11-6 |
|
|